U
LLY icon

UBS’s Eli Lilly LLY Stock Holding History

UBS’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$45.9M Buy
707,528
+38,330
+6% +$2.43M 0.03% 545
2014
Q2 		$41.6M Buy
669,198
+6,083
+0.9% +$363K 0.03% 532
2014
Q1 		$39M Sell
663,115
-137,226
-17% -$7.66M 0.03% 488
2013
Q4 		$40.8M Sell
800,341
-112,650
-12% -$5.64M 0.04% 469
2013
Q3 		$46M Buy
912,991
+44,211
+5% +$2.31M 0.05% 364
2013
Q2 		$42.7M Buy
+868,780
New +$47.3M 0.05% 361

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS's LLY Position: Q3 2014 in Review

UBS increased its Eli Lilly (LLY) stake by 5.7% in Q3 2014, buying an estimated $2.43M and bringing the position to 707,528 shares worth $45.9M. The position accounts for 0.03% of the portfolio, ranked #545.

UBS first reported a position in LLY in Q2 2013 and has held it in 6 quarters since. The position peaked at $46M in Q3 2013. 1,041 funds tracked by Wall St. Rank hold LLY as of Q3 2014.

  • UBS held 707,528 shares of Eli Lilly worth $45.9M as of Q3 2014.
  • UBS bought 38,330 Eli Lilly shares in Q3 2014, an estimated $2.43M.
  • Eli Lilly made up 0.03% of UBS's portfolio in Q3 2014, its #545 holding.
  • UBS first reported a position in Eli Lilly in Q2 2013 and has held it in 6 quarters since.
  • UBS's Eli Lilly position peaked at $46M in Q3 2013.
  • 1,041 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.